Overcoming the common solubility challenges in targeted oral therapy development

Solubility Enhancement Strategies For Targeted Oral Therapies

Capture key insights into advancing the development of targeted oral therapies by overcoming common challenges in solubility, permeability, and overall bioavailability. Learn more about leveraging novel enabling technologies and strategic partnerships, with executive perspectives from a Citeline roundtable discussion, featuring an expert from PCI Pharma Services.

Download the summary to learn more about:

What targeted oral therapy developers say are their biggest universal challenges
How to take the first step in selecting the appropriate new solubility - and bioavailability-enhancing technologies
When formulation and process development for targeted oral therapies should be done
Why partnering with a specialist CDMO can give developers a key competitive advantage

Register for the Summary

Your Company Email Address

Opt In?

By completing this form you agree Citeline and PCI Pharma Services may store and process your personal data as well as contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy policies of Citeline and PCI Pharma Services.